#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Heart disease congenital Follicular lymphoma stage I Autoimmune disorder Peritoneal mesothelioma malignant Polyneuropathy Immune-mediated enterocolitis Deafness Chronic inflammatory demyelinating polyradiculoneuropathy Undifferentiated sarcoma Hodgkin's disease recurrent Epilepsy with myoclonic-atonic seizures Blood iron increased Multiple system atrophy Neuronal ceroid lipofuscinosis Orthostatic hypotension More trials…

    Learn about Rare Diseases

    Congenital hypotransferrinaemia – Life with Disease Acute respiratory distress syndrome – Life with Disease Shprintzen-Goldberg syndrome – Basic Information Optic glioma – Treatment Glycogen storage disease type V – Trials in Disease Isodicentric chromosome 15 syndrome – Diagnostics Wolfram syndrome Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Mucopolysaccharidosis – Trials in Disease Acquired haemophilia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Moxifloxacin Cevostamab Levocarnitine Poa Pratensis Pollen Extract Fosaprepitant Polatuzumab Vedotin Sodium Glycerophosphate Omeprazole Nicotine Resinate Phenprocoumon Clebopride Hydrogen Maleate TETRODOTOXIN Metoprolol Linerixibat Salmeterol Xinafoate Clemastine Ethinylestradiol Gs-5245 Ambrosia Artemisiifolia (302) TAZAROTENE More therapies…

    Learn about Your Condition

    Lymphangiosarcoma Head injury Lichenoid keratosis Acute hepatic failure Liver transplant rejection Peripheral artery angioplasty Carpal tunnel syndrome Skin neoplasm excision Hip fracture Melanoma recurrent Angina pectoris Neuroblastoma recurrent Breast cancer stage IV Hyperparathyroidism secondary Aortic valve stenosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Oscar Lambret

Centre Oscar Lambret

3 Rue Frederic Combemale, Lille, 59000, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Adjusting Chemotherapy with Carboplatin and Paclitaxel for Patients with Poor Prognostic Ovarian Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Bevacizumab
    • Carboplatin
    • Filgrastim
    France Italy The Netherlands

  • Phase 1/2 Study of pumitamig Alone or Combined with ipilimumab or cabozantinib in Patients with Advanced Renal Cell Carcinoma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Cabozantinib
    • Ipilimumab
    Czechia Finland France Germany Ireland Italy +2

  • A Phase 3 Study of GSK5733584 with drug combination in patients with platinum‑resistant ovarian cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Bevacizumab
    • Doxorubicin Hydrochloride
    • Gemcitabine Hydrochloride
    Austria Belgium Czechia Denmark Finland France +7

  • A Phase III Randomized Trial of Trilaciclib Dihydrochloride versus Placebo in Adults with Limited‑Stage Small Cell Lung Cancer

    Not yet recruiting

    3 1
    Investigated Diseases:
    • Small cell lung cancer limited stage
    Belgium Czechia France Germany Greece Spain

  • Second‑line ivonescimab plus chemotherapy drug combination versus bevacizumab in patients with metastatic colorectal cancer without liver metastases

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Bevacizumab
    • Fluorouracil
    • Folinic Acid
    France

  • Phase I/II Study of Dinutuximab Beta, Irinotecan, and Sirolimus in Children, Adolescents, and Adults with Relapsed or Refractory Bone Sarcoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Chondrosarcoma
    • Osteosarcoma
    • Ewing’s sarcoma
    Investigated Drugs:
    • Dinutuximab Beta
    • Irinotecan Hydrochloride Trihydrate
    • Sirolimus
    France

  • Phase 1/2 Study of Oral TRI-611 in Adults With Advanced ALK‑Positive Non‑Small Cell Lung Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    France Germany Italy Spain

  • Evaluation of Cefazolin versus Placebo for Preventing Surgical Site Infection in Breast Cancer Lumpectomy Patients

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Cefazolin Sodium
    • Sodium Chloride Ph. Eur.
    • Sodium Hydrogen Carbonate Pheur
    France

  • Study of Camizestrant and Abemaciclib in Patients with ER‑positive HER2‑negative Metastatic Breast Cancer Who Show Rising ctDNA

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Abemaciclib
    • Camizestrant
    France

  • Durvalumab personalized consolidation immunotherapy after chemoradiotherapy in patients with stage III non‑small cell lung cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer stage III
    Investigated Drugs:
    • Durvalumab
    France
Previous Page
1 … 11 12 13 14 15 … 26
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!